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Available online 28 April 2008Alphavirus vectors express high levels of recombinant proteins inmammalian cells, but their cytopathic nature
makes this expression transient. In order to generate a Semliki Forest virus (SFV) noncytopathic vector we
introducedmutations previously described to turn Sindbis virus noncytopathic into a conserved position in an
SFV vector expressing LacZ. Interestingly, mutant P718T in replicase nsp2 subunit was able to replicate in only a
small percentage of BHK cells, producing β-gal-expressing colonies without selection. Puromycin N-acetyl-
transferase (pac) gene was used to replace LacZ in this mutant allowing selection of an SFV noncytopathic
replicon containing a secondmutation in nsp2 nuclear localization signal (R649H). This lattermutation did not
confer a noncytopathic phenotype by itself and did not alter nsp2 nuclear translocation. Replicase synthesis
was diminished in the SFV double mutant, leading to genomic and subgenomic RNA levels that were 125-fold
and 66-fold lower than in wild-type vector, respectively. Interestingly, this mutant expressed β-gal levels
similar to parental vector. By coexpressing pac and LacZ from independent subgenomic promoters this vector
was able to generate stable cell lines maintaining high expression levels during at least 10 passages, indicating
that it could be used as a powerful system for protein production in mammalian cells.
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Alphavirus expression vectors have been developed from different
viruses, which include Sindbis virus (SIN) (Xiong et al., 1989), Semliki
Forest virus (SFV) (Liljestrom and Garoff, 1991) and Venezuelan equine
encephalitis virus (VEE) (Pushko et al., 1997). Alphavirus vectors are
usually based on RNA replicons inwhich the viral structural genes have
been deleted and substituted by a heterologous gene. The alphavirus
replicon contains an ORF coding for the viral replicase at its 5′ end,
which is translated upon transfection of the RNA into eukaryotic cells.
Replicase is expressed as a polyproteinwhich is sequentially processed
into four subunits (nsps 1–4) (Strauss and Strauss,1994; Vasiljeva et al.,
2003). Unprocessed replicase can copy the RNA vector into a negative
strand RNA, a process which only takes place during the ﬁrst 3–4 h of
transfection/infection. Upon processing, the replicase will use the
negative strand RNA as template to make more replicon molecules.
Processed replicase can also recognize an internal sequence in the
negative strand RNA, or subgenomic promoter, from which it will
synthesize a subgenomic positive strand RNA corresponding to the 3′
end of the replicon, which contains the sequence of the heterologous
gene. This subgenomic RNA will be translated to produce the
heterologous protein at very high levels. The replicon RNA can also beResearch (CIMA), University of
: +34 948 194717.
l rights reserved.packaged into viral particles by cotransfecting cells with one or more
helper RNAs that are able to provide the viral structural proteins in trans
(Berglund et al., 1993; Bredenbeek et al., 1993; Frolov et al., 1997;
Pushko et al., 1997; Smerdou and Liljestrom, 1999), or by using
packaging cell lines (Polo et al., 1999). The replication of alphavirus
vectors is cytopathic in most mammalian cells, due to mechanisms
which are not yet fully understood (Berglund et al., 1998; Frolov and
Schlesinger, 1994a; Glasgow et al., 1997). The cytopathic effect induced
by these vectors is mediated by p53-independent apoptosis, and it
usually takes place at 48–72 h posttransfection/infection (Glasgow
et al., 1998). It is suspected that nsp2, one of the 4 components of the
viral replicase could playan important role in the induction of apoptosis
(Frolova et al., 2002; Garmashova et al., 2006).
Alphavirus cytopathic vectors have been used for a number of
applications including in vitro protein production and characteriza-
tion (Wurm and Bernard,1999), as well as vaccination and cancer gene
therapy studies (Lundstrom, 2003; Rayner et al., 2002). However, one
important drawback of the original vectors is the fact that they cannot
be used in applications where long expression of the transgene is
desired. In order to solve this problem several groups have identiﬁed a
number of mutations in the alphavirus replicase that are able to
render these vectors noncytopathic, allowing a more prolonged
expression of the recombinant products expressed by the vector.
These studies have led to the description of noncytopathic vectors
derived from SIN (Frolov et al., 1999; Perri et al., 2000), SFV
(Lundstrom et al., 2003, 2001; Perri et al., 2000) and more recently
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mutations detected in alphavirus have been mapped in the nsp2
subunit of the replicase. This protein contains an amino-terminal
domain with nucleoside triphosphatase and helicase activities and a
protease carboxy-terminal domain involved in the processing of
replicase into its four subunits (Strauss and Strauss, 1994). It has been
shown that a number of noncytopathic mutations described for nsp2
affect either the proteolytic domain of nsp2, or positions close to
cleavage sites between nsp1/2 and nsp2/3, altering in this way the
processing of replicase. A well characterized noncytopathic mutant
isolated from SIN that contained a single amino acid change (P to L) at
position 726 in nsp2 showed a hyperprocessing of the replicase
(Frolov et al., 1999). This mutant was able to efﬁciently establish
persistent replication in BHK cells. The introduction of different amino
acid changes at the same position in this mutant showed that there
was a strong positive correlation between the level of RNA replication
and the cytopathogenicity of the vector. The SIN noncytopathic vector
containing P726L mutation in nsp2 has been widely used in vitro, and
although it was able to provide long transgene expression with a
rather high stability, its expression level was only about 4% of that
described for the parental SIN vector (Agapov et al., 1998). In the case
of the described SFV noncytopathic vectors a level of heterologous
expression similar or higher than the one observed with the SFV
parental vector has been reported (Lundstrom et al., 2001; Perri et al.,
2000). However, in many cases the stability of these vectors was low,
leading to loss of expression within a few days (Lundstrom et al.,
2003).
The purpose of the present studywas to develop newnoncytopathic
SFV vectors able to provide high expression levels of recombinantFig. 1. Evaluation of the cytopathogenicity of SFV vectors carrying mutations derived from SI
LacZ) in nsp2 were constructed as described in Materials and methods. RNA was transcr
electroporated into BHK cells which where plated on 35-mm-diameter dishes at low conﬂue
S2-LacZ or SFV-S3-LacZ, transfected cells were passaged 1:5 after 96 h in culture. Very few po
A schematic representation of each vector RNA is shown above each set of pictures. Circ
subgenomic promoter; An, poly A.proteins. Since SFVandSIN share a high degree of sequence similarity in
the nonstructural proteins we tested the possibility of generating new
SFV noncytopathic mutants by introducing mutations described at the
nsp2 726 position in SIN into the homologous sequence of SFV nsp2. To
our surprise these mutations were not able to provide a noncytopathic
phenotype by themselves but led to the appearance of noncytopathic
SFV variants containing second adaptive mutations. We isolated in this
way a new noncytopathic SFV vector containing mutations P718T and
R649H in nsp2. This vector was characterized in detail, showing RNA
levels in transfected cells that were 125-fold lower than those of the
parental SFV vector. In spite of the low replication levels the new SFV
double mutant was able to express heterologous proteins at levels
similar to those of wt SFV vector.
Results
Construction and characterization of SFV vectors carrying noncytopathic
mutations derived from SIN
We have evaluated the effect of noncytopathic mutations described
in SIN in an expression vector derived from SFV. Two mutations
affecting residue 726 in the nsp2 subunit of SIN replicase, P726T and
P726F, which had been described as partially cytopathic and noncyto-
pathic for SIN, respectively, were introduced into the homologous nsp2
residue in pSFV-1 plasmid, generating mutants pSFV-S2 and pSFV-S3,
which carried mutations P718T or P718F in nsp2, respectively. In order
to evaluate the cytopathogenicity of these new vectors reporter gene
LacZ was cloned downstream of the viral subgenomic promoter,
generating pSFV-S2-LacZ and pSFV-S3-LacZ, respectively. RNA wasN. SFV-LacZ plasmids containing mutations P718T (pSFV-S2-LacZ) and P718F (pSFV-S3-
ibed in vitro from each of these plasmids as well as from parental pSFV3-LacZ and
nce and stained with X-gal after being cultured for the indicated times. In the case SFV-
sitive cells where observed in SFV-S3-LacZ transfected dishes at 120 h posttransfection.
le at the left end of vectors, cap; nsp, non structural proteins; horizontal arrow, SFV
244 E. Casales et al. / Virology 376 (2008) 242–251synthesized in vitro from each of these plasmids and electroporated
into BHK-21 cells which were cultured and analyzed for β-gal ex-
pression by X-gal staining at different times posttransfection (Fig. 1). In
contrast to cells electroporated with control SFV-LacZ RNA where at
24 h posttransfection more than 95% of the cells expressed β-gal and
showed a cytopathic phenotype, only a small percentage (about 1%)
of cells transfected with SFV-S2-LacZ or SFV-S3-LacZ RNAs expressed
β-gal at early times posttransfection, not showing a cytopathic
morphology. In the case of SFV-S2-LacZ the number of positive cells
increased along time, being able to form large colonies of β-gal
expressing cells at day 5 postelectroporation. This effect was much
more attenuated in SFV-S3-LacZ,where no blue colonieswere observed
at day 5 after X-gal staining. These data suggested thatmutations P718T
and P718F might block viral replication or transgene expression, but
give rise with a relative high frequency to noncytopathic variants that
could be the result of second adaptive mutations appearing during in
vitro transcription or SFV replication.
Selection and mapping of replicons derived from SFV-S2 containing new
adaptive mutations
In order to select cell populations containing SFV noncytopathic
replicons we substituted reporter gene LacZ in pSFV-S2-LacZ by the
dominant selectable marker puromycin N-acetyl-transferase (pac)
conferring puromycin resistance (de la Luna et al., 1988), generating
pSFV-S2-pac. Using this plasmid as template RNA was synthesized in
vitro and electroporated into BHK-21 cells. At 24 h postelectroporation
puromycin was added at 5 μg/ml, leading to the selection of drug
resistant colonies, which were subsequently expanded. In order to
identify putative adaptivemutations in the repliconspresent in selected
cells total RNA was extracted from individual clones and a 3.9 kb
fragment from the SFV replicase comprising whole nsp2 sequence was
ampliﬁed by RT-PCR. We chose to amplify the nsp2 region of the
replicase because most noncytopathic mutations described in alpha-
viruses have been mapped in this region. The cDNA fragment rescuedFig. 2. Puromycin resistant cells selected after electroporation of BHK cells with RNA. BHK ce
RNA), plated on 35-mm-diameter dishes, and allowed to recover for 24 h before the addition
posttransfection.from each clone was subcloned into parental pSFV-pac plasmid
substituting the wild-type (wt) nsp2 sequence. In order to check if
noncytopathic mutations had been rescued RNA was synthesized in
vitro from each of the new plasmids and used to electroporate BHK-21
cells as described. 24 h after transfection puromycinwas added at 5 μg/
ml and cells were stained with crystal violet at different times to
compare their growth to that observed in cells transfected with the
original SFV-S2-pacmutant orwith parental SFV-pac. One of the clones,
SFV-S2-9-pac, showed a clear noncytopathic phenotype since it
conferred puromycin resistance to most transfected cells (Fig. 2).
Other clones that were tested showed a pattern similar to that of SFV-
S2, suggesting that theycould contain additionalmutations in anarea of
the replicase different fromnsp2, but theywere not further analyzed for
this study. Cells transfected with parental SFV-pac showed a clear
cytopathic effect and most of them died before day 4. Sequencing of
nsp2 fragment from pSFV-S2-9-pac showed that in addition to the
original mutation P718T there was a second adaptive mutation in
position 649 of nsp2 where Arg had been substituted by Hys. This new
mutation affects the SFV nsp2 nuclear localization signal 648RRR
(Rikkonen, 1996) which in SFV-S2-9 changes to 648RHR.
Effect of the R649H mutation on cytopathogenicity and on nsp2 nuclear
localization
In order to check the effect of mutation R649H by itself on the
cytopathogenicity of SFV, this mutation was introduced into pSFV-pac
as described in Materials and methods, generating plasmid pSFV-RHR-
pac. RNA was transcribed from this plasmid and electroporated into
BHK-21 cells,whichwere left to recover for 24 h. At this timepuromycin
was added at 5 μg/ml and cell growthwas analyzed at different times by
staining the cells with crystal violet as described previously (Fig. 2, SFV-
RHR-pac column). SFV-RHR-pac showed a pattern very similar to that
observed for parental vector SFV-pac, inducing an early strong
cytopathic effect that led to death of most cells before day 4. These
results suggested that lack of cytopathogenicity of vector SFV-S2-9 waslls were electroporated with the indicated SFV RNA vectors, or mock electroporated (no
of puromycin at 5 μg/ml. Dishes were stained with crystal violet at the indicated times
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check the effect of R649H mutation on nsp2 nuclear localization, cells
were transfectedwith RNA fromvectors containing thismutation (SFV-
S2-9-pac and SFV-RHR-pac) or with vectors that did not have it (SFV-
pac and SFV-S2-pac) and analyzed by immunoﬂuorescence with
antibodies speciﬁc for the nuclear or the cytoplasmic form of SFV
nsp2, respectively (Fig. 3A). In all cases nsp2 was detected both in the
nucleus and in the cytoplasm of transfected cells. In order to determine
if the percentage of nsp2 translocated to the nucleus had been affected,
cytoplasmic and nuclear fractions from the same cells were separated
and analyzed by Western blot with a polyclonal antiserum speciﬁc for
nsp2 (Fig. 3B). The nsp2 cytoplasmic/nuclear ratio was very similar in
cells transfected with any of the vectors suggesting that mutation
R649H was not affecting nuclear trafﬁcking of this protein.
RNA replication in SFV-S2-9-pac transfected cells
In order to determine the level of RNA replication of the double SFV
noncytopathic mutant BHK cells were electroporated with SFV-S2-9-
pac, total RNAwas extracted at 24, 48, and 72hpostelectroporation, and
analyzed by Northern blot with a 32P-labeled oligonucleotide speciﬁc
for the SFV subgenomic promoter sequence which is present in bothFig. 3. Analysis of nsp2nuclear transport. BHKcellswere electroporatedwith the indicated SFV
Western blot (B) at 24 h posttransfection. A) Intracellular localization of nsp2 in cells transf
cytoplasmic (nsp2-c) forms of nsp2were used as primary antibodies, and a polyclonal rabbit-an
nuclei of the same cells were visualized with a UV ﬁlter (dapi). Images correspond to represen
analysis of nsp2 in cytoplasmic (c) and nuclear fractions (n) of transfected cells. Samples were
gel). As controls the same samples were analyzedwith an antibody speciﬁc for a cytoplasmic p
gels indicate the mean and standard deviation values for the ratio of cytoplasmic/nuclear nspgenomic and subgenomic RNAs (Fig. 4, lanes 2–4). The level of genomic
and subgenomic SFV-S2-9-pac RNAs, as well as the ratio between them
was compared to that obtained in cells transfected with parental SFV-
pac at 24 h postelectroporation (Fig. 4, lane 5). SFV-S2-9-pac genomic
and subgenomic RNAs increased with time seeming to reach a peak at
48 h postelectroporation (Fig. 4, lanes 2–4). Similar RNA levels were
observed in a BHK puromycin resistant cell line obtained with SFV-S2-
9-pac (Fig. 4, lane 1). In all cases SFV-S2-9 RNAswere produced at levels
much lower than those obtained in cells transfected with the parental
SFV-pac RNA (notice that lanes 1–4 in Fig. 4 were exposed 72 times
longer than lane 5). Quantiﬁcation of RNA levelswith a phosphorimager
resulted in125-fold and66-fold less genomicRNAand subgenomicRNA
levels, respectively, in cells stably transfected with SFV-S2-9-pac as
compared to cells transfected with SFV-pac. The subgenomic/genomic
RNA ratio observed in SFV-S2-9-pac selected cells was about two-fold
higher than that observed in cells transfected with SFV-pac (Fig. 4,
bottomnumbers). However, in SFV-S2-9-pacnonselected cells this ratio
was considerably higher, especially at 24 h after transfection, but
diminished along time, indicating that synthesis of genomic RNA in the
double mutant could be delayed with respect to that of subgenomic
RNA. Two additional RNA bands with an intermediate size between
genomic and subgenomic RNAs were also detected in cells transfectedRNAvectors ormock electroporated (noRNA) andanalyzedby immunoﬂuorescence (A) or
ected with SFV RNA. Mouse monoclonal antibodies speciﬁc for the nuclear (nsp2-n) or
timouse IgG serum conjugatedwith FITCwas used as a secondary antibody. Dapi-stained
tative ﬁelds of one out of three experiments yielding a very similar result. B) Quantitative
analyzed by Western blot by using a rabbit polyclonal antiserum speciﬁc for nsp2 (upper
rotein (GAPDH,middle gel) or for a nuclear protein (lamin, lower gel). Numbers below the
2 in each case, and correspond to three independent experiments.
Fig. 4. Analysis of SFV RNAs in BHK transfected cells. Total RNA was extracted from a stable BHK cell line obtained after electroporation of SFV-S2-9-pac replicon and selection with
puromycin (lane 1) or from BHK cells electroporated with SFV-S2-9-pac (lanes 2–4), SFV-pac (lane 5), SFV-LacZ (lane 6) or coelectroporated with SFV-S2-9-pac and SFV-pac (lane 7)
replicons and analyzed at 24 h (lanes 2, 5–7), 48 h (lane 3), or 72 h (lane 4) postelectroporation. The amount of genomic (g) and subgenomic (sg) SFV RNAs was analyzed by Northern
blot with a 32P-oligonuclotide speciﬁc for SFV subgenomic promoter as described in Materials and methods. The numbers at the bottom of the gels indicate the ratio of sg/g RNAs in
each case. In lane 7 they refer to sg/g RNA ratio of SFV-S2-9-pac (pac) or SFV-LacZ (LacZ), respectively. A representative experiment is shown in which all samples were run on the
same gel and transferred to nitrocellulose simultaneously. The left part of the gel (lanes 1–4) was exposed for 72 h while the right part (lanes 5–7) was exposed for 1 h.
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characterized but could correspond to defective interfering RNAs
appearing during the replication of the double SFV mutant. Finally, in
order to determine if the low levels of SFV-S2-9-pac RNA replication
could be rescued by a wt replicase, BHK cells were simultaneously
electroporated with SFV-S2-9-pac and parental SFV-LacZ RNAs. 24 h
later total RNAwas extracted from coelectroporated cells and analyzed
by Northern blot as described (Fig. 4, lane 7). RNA from cells
electroporated with parental SFV-pac (Fig. 4, lane 5) and SFV-LacZ
(Fig. 4, lane 6)were analyzed in the same gel and used asmolecular size
markers for each of the genomic and subgenomic RNAs. Both SFV-LacZ
and SFV-S2-9-pac genomic and subgenomic RNAswere easily detected
in coelectroporated cells after a short exposure of the gel, indicating that
wt replicase was able to at least partially rescue replication of the
doublemutant. However, although the levels of both subgenomic RNAs
were very similar, parental SFV-LacZ genomic RNA was produced atFig. 5. In vitro and in vivo expression of nonstructural proteins. A) Parental SFV-pac RNA (wt
the presence of [35S]methionine and [35S]cysteine, and analyzed by SDS-PAGE on 8% gels foll
lengths of time in order to obtain a better separation of high molecular bands (upper gel, lon
shorter run). B) Analysis of replicase expression in transfected cells. Lysates from cells electro
BHK cells (C), were analyzed byWestern blot at different times postelectroporation by using
nsp2 expressed by SFV-S2-9-pac or SFV-RHR-pac, respectively, at different time points is indi
2 independent experiments. The arrow indicates an unspeciﬁc band used as loading control. ⁎
M, lane loaded with molecular weight markers (sizes indicated between gels).levels which in average were about 2–3 times higher than those of the
SFV-S2-9-pac genomic RNA.
Replicase processing in the SFV-S2-9 mutant
The lower RNA levels detected in cells transfected with the SFV-S2-
9-pac replicon could be due to an alteration in the processing of the
replicase. SFV replicase is synthesized as polyprotein nsp1234which is
subsequently cleaved into its mature monomeric components by the
protease activity present in the carboxy-terminal domain of nsp2
(Strauss and Strauss, 1994; Vasiljeva et al., 2003), where both P718T
and R649H mutations have been mapped. In order to examine the
effect of these mutations on replicase processing, SFV-S2-9-pac and
SFV-RHR-pac RNAswere translated in rabbit reticulocyte lysates in the
presence of [35S]methionine and [35S]cysteine. The processing pattern
of the replicase in these mutants was compared to that obtained for) or the indicated mutant SFV-pac RNAs were translated in rabbit reticulocyte lysates in
owed by autoradiography. Two gels containing the same samples were run for different
ger run), and to detect the lower molecular weight monomers nsp1, 3 and 4 (lower gel,
porated with the indicated mutant SFV-pac RNAs, parental SFV-pac (wt) or from control
a rabbit polyclonal antiserum speciﬁc for nsp2. The ratio of nsp2 expressed by SFV-pac/
cated below the gel. Numbers correspond to the mean and standard deviation of at least
Highmolecular bands with size similar to nsp123 (upper band) and nsp12 (lower band).
Fig. 6. Analysis of β-gal expression. BHK cells were electroporated with the indicated
RNAs and the level of β-gal expression per cell was determined at the indicated times
postelectroporation.
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No differences were observed in the processing of the replicase
between the two analyzedmutants and thewt replicase, resulting in a
similar accumulation of nsp monomers in all cases. In order to
determine if replicase processing was affected in vivo, BHK cells were
electroporated with SFV-S2-9-pac, SFV-RHR-pac or SFV-pac RNAs and
cell lysates were analyzed at different times posttransfection by
Western blot with a rabbit antiserum speciﬁc for nsp2 (Fig. 5B). The
amount of nsp2 synthesized by the three analyzed vectors was very
similar at 2 h posttransfection but increased considerably after 4 h in
cells transfected with SFV-RHR-pac or SFV-pac, which correlated with
the higher replication level of these two vectors. In addition to the
nsp2 monomer two high molecular bands were detected in cells
transfected with SFV-RHR-pac or SFV-pac RNA at 4 h posttransfection
which could correspond to partially processed replicase (Fig. 5B).
These bands, which could correspond by size to intermediates nsp123
and nsp12, were almost undetectable in cells transfected with SFV-S2-
9-pac RNA, suggesting a quicker processing of the replicase in this
mutant. The lowest of these high molecular bands was also processed
more slowly in cells transfected with SFV-RHR-pac as compared to
SFV-pac (Fig. 5B, 24 h), which could also be indicating that mutation
RHR by itself can have a slight effect on replicase processing.
Packaging of SFV-S2-9 replicon
To facilitate this study reporter gene LacZ was cloned downstream
of the SFV subgenomic promoter in pSFV-S2-9, generating plasmid
pSFV-S2-9-LacZ. To determine the packaging efﬁciency of this vector
BHK cells were coelectroporated with SFV-S2-9-LacZ and SFV helper-S
and SFV helper C-S219A RNAs as described (Smerdou and Liljestrom,
1999). Cell supernatants were collected at 24 h postelectroporation
and titrated on BHKmonolayers by X-gal staining (Table 1). SFV-S2-9-
LacZ RNA was packaged with a very low efﬁciency yielding titers of
7×103 vp/ml, which were much lower than those obtained with
parental SFV-LacZ (5×109 vp/ml). In order to check if the presence of
the wt replicase could increase the packaging efﬁciency of the double
S2-9 mutant, BHK cells were coelectroporated with SFV-S2-9-LacZ,
SFV-pac, and both SFV helper RNAs. In this case it was observed that
parental SFV vector was able to moderately increase the production of
SFV-S2-9-LacZ particles, which reached a titer of 1×105 vp/ml at 24 h
postelectroporation, as determined by X-gal staining of BHK infected
cells. Packaging of parental SFV-pac was only reduced about 5-fold in
cells in which this vector was coelectroporated with SFV-S2-9-LacZ
when compared to titers obtained when SFV-pac was packaged alone
(determined by indirect immunoﬂuorescence of infected cells using a
rabbit polyclonal antiserum speciﬁc for SFV-nsp2 as primary anti-
body) (Table 1). In order to determine the effect of each of the
two individual mutations present in SFV-S2-9 in packaging, BHK cells
were coelectroporated with both SFV helper RNAs and with eitherTable 1
Titers of recombinant particles containing SFV mutant replicons
Packaged replicon Titer X-gala Titer replicase+b
(particles/106 cells)c (particles/106 cells)c
SFV-LacZ 5×109 ND
SFV-S2-9-LacZ 7×103 ND
SFV-S2-9-LacZ+SFV-pac 1×105 3.3×108
SFV-pac ND 2.7×109
SFV-RHR pac ND 6.5×108
SFV-S2-pac ND 2×104
N.D. Not determined.
a Particles were titrated by X-gal staining of infected cells.
b Particles were titrated by immunoﬂuorescence of infected cells with a polyclonal
antiserum speciﬁc for SFV replicase.
c The titers are the average of at least three independent experiments that yielded
very similar results.SFV-RHR-pac or SFV-S2-pac RNAs, and viral particles were titrated as
described above for SFV-pac. SFV-RHR-pac was packaged at high titers
(6.5×108 vp/ml) while SFV-S2-pac showed a very low efﬁciency of
packaging (2×104 vp/ml).
Transgene expression in cells transfected with the SFV-S2-9 replicon
To determine the level of heterologous gene expression in the SFV
doublemutant RNAwas synthesized in vitro from pSFV-S2-9-LacZ and
used to electroporate BHK cells, in which β-gal expression was
analyzed at different times postelectroporation. For comparison cells
were also transfected with parental SFV-LacZ RNA, but were only
analyzed at 24 h postelectroporation due to the cytopathic effect
induced by this vector. A similar level of β-gal expressionwas observed
in SFV-S2-9-LacZ and SFV-LacZ transfected cells at 24 h posttransfec-
tion, which was in the range of 15 pg/cell (Fig. 6). This expression level
increased along time in cells transfected with SFV-S2-9-LacZ reaching
a plateau of approximately 30 pg of β-gal/cell at 48 h posttransfection.
Production of a stable cell line expressing LacZ by using the SFV-S2-9
vector
As it has been shown in this study the SFV-S2-9-pac vector can be
used to select cells that are able to maintain the replicon in theFig. 7. Stability of β-gal expression in cells transfected with SFV-S2-9-LacZ-pac. BHK
cells were electroporated with SFV-S2-9-LacZ-pac RNA and selected in the presence of
puromycin at 5 μg/ml. Selected cells were passaged every 2–3 days with or without
puromycin and the percentage of β-gal positive cells was determined at each passage by
X-gal staining. The data correspond to the mean of three independent experiments,
with the standard deviation shown. The picturewithin the graph shows a typical ﬁeld of
BHK cells containing SFV-S2-9-LacZ-pac passaged 9 times in the presence of puromycin
and stained with X-gal.
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type of vector to generate stable cell lines expressing other transgenes
reporter gene LacZ was introduced into pSFV-S2-9-pac, generating
plasmid pSFV-S2-9-LacZ-pac, in which pac and LacZ genes are placed
downstream of independent subgenomic promoters. RNA was
synthesized in vitro from this plasmid and electroporated into BHK
cells. At 24 h postelectroporation puromycinwas added at 5 μg/ml and
when selected cells reached conﬂuency they were passaged ten times
in the presence of the antibiotic during a period of 28 days. The
percentage of β-gal-expressing cells, determined in each passage by
X-gal staining, varied between 70% and 90%, but was 85% at passage
10, indicating a very high stability of transgene expression in the
presence of selection (Fig. 7). When selected cells were passaged
without puromycin the percentage of β-gal-expressing cells dimin-
ished very quickly, being below 5% after 3 passages. The level of β-gal
expression in cells selected with puromycin was determined after 6
and 8 passages (corresponding to 18 and 24 days in culture,
respectively), reaching 13 and 18 pg/cell, respectively. These values
are very similar to those obtained in cells transfected with parental
vector SFV-LacZ at 24 h posttransfection, indicating that cell lines
generated with the SFV-S2-9 vector could be used to express
recombinant proteins at high levels.
Discussion
Most noncytopathic alphavirus mutants that have been described
carry mutations in nsp2. However, in spite of a high percentage of
sequence similarity between different alphaviruses, these mutations
affected different residues in different viruses. Taking advantage of
this sequence homology we investigated the effect of a well
characterized SIN noncytopathic mutation affecting residue 726 of
nsp2 in the context of SFV. Mutations P726L and P726T had been
described as noncytopathic by Frolov et al. (1999) and by Perri et al.
(2000), respectively. In the ﬁrst study residue 726 was also
mutagenized to all other possible residues, generating a collection of
SIN mutants with different degrees of cytopathogenicity. Frolov et al.
(1999) were able to establish a correlation between the level of RNA
replication and the cytopathogenicity, concluding that those changes
in nsp2 726 that reduced RNA levels to less than 5% of the wt vector
produced a noncytopathic phenotype. We chose two different
changes, P726T and P726F which were able to reduce RNA levels in
SIN to 5.1% and 1.6%, respectively, and introduced the corresponding
mutations in the equivalent position 718 of SFV nsp2 (S2 and S3
mutants respectively). None of these changes was able to produce a
noncytopathic phenotype in SFV by itself. Studies performed by
transfecting cells with these mutants carrying reporter gene LacZ
showed that only a small percentage of transfected cells were able to
sustain the replication of the vector. The S2 mutant (P718T) seemed to
be more stable than S3 (P718F) giving rise to large colonies of positive
cells in the absence of selection. We hypothesized that these colonies
contained replicons with additional adaptive mutations. In order to
select these colonies and identify the putative second mutations
present in the replicons we cloned the N-acetyl-transferase (pac) gene
into the SFV S2 mutant and isolated cell colonies grown in the
presence of puromycin. In one of the analyzed clones we found a
second mutation at position 649 of nsp2 (R649H), which in
combination with P718T was able to provide a noncytopathic
phenotype to the SFV vector. Mutation R649H affects the 648RRR
nuclear localization signal of SFV which has been described as being
responsible for partial transport of nsp2 to the cell nucleus (Rikkonen,
1996). The change of Arg by Hys at position 649 constitutes a very
conservative change, which could explain the fact that no apparent
effect on nsp2 nuclear transport was observed either in the double S2-
9 mutant or in the single R649H mutant. The latter mutant did not
show any reduction in cytopathogenicity as compared to the parental
SFV vector, indicating that both mutations at positions 649 and 718were required to suppress the cytopathic effect. A more drastic change
at the 649 position (R649D) had been previously described by
Fazakerley et al., (2002) leading to the attenuation of the neuroviru-
lence of SFV in the context of a full viral genome. In that case mutation
R649D completely disrupted nsp2 transport to the nucleus, although
it did not abolish the cytopathic effect of the virus on BHK cells. All
together these data suggest that the 648RRR sequence of nsp2 could be
involved in the cytopathogenicity of SFV, although more detailed
mutagenesis studies will be required to determine the precise role of
this sequence on the induction of cell death.
The S2-9 mutant was able to replicate at levels which were about
125 times lower than those observed for the wt SFV vector, which
could explain the lack of cytopathogenicity of this vector. The level of
subgenomic RNA in S2-9 was only 66 times lower than that of the wt
SFV vector, indicating that the ratio of subgenomic/genomic RNA was
increased about two-fold in the noncytopathic mutant. Both the
decrease in RNA levels and the increase in the subgenomic/genomic
RNA ratio observed for S2-9were very similar to those described in SIN
vectors containing noncytopathic mutations in position 726 of nsp2
(Frolov et al., 1999; Perri et al., 2000; Sawicki et al., 2006). However,
these results are in contrast with those described by Perri et al. (2000)
for SFV noncytopathic mutants where RNA levels where higher than
those of wt virus, and in which also subgenomic/genomic RNA ratios
were decreased, suggesting that different mechanisms could be
involved in the establishment of persistent replication in the SFV
mutants isolated by this group. The lower level of RNA replication in
S2-9 was not due to a cis effect of mutations present in the RNA
sequence, as it was shown by the fact that awt replicase provided from
a parental SFV vector could rescue the S2-9 genomic and subgenomic
RNA levels to values close to those of wt SFV vector.
Synthesis of replicasewas diminished in cells transfectedwith S2-9
after 4 h posttransfectionwhich can contribute to the lower replication
level of this mutant. The lower replicase expression at 24 h
posttransfection is in contrast with the high level of heterologous
protein expression observed in cells transfected with SFV-S2-9-LacZ,
but could be due to the higher subgenomic/genomic RNA ratio present
in S2-9 mutant. At 24 h posttransfection this ratio is about 4-fold
higher in S2-9with respect towt (Fig. 4), indicating that the amount of
available S2-9 genomic RNA that can be translated to produce the
replicase is very limited. Since the amount of S2-9 genomic RNA
increases after 24 h posttransfection the amount of expressed replicase
will probably be higher at later times. In fact the amount of nsp2 in a
stable cell line containing a SFV-S2-9-pac replicon is only 1.5-fold
lower than in wt transfected cells (data not shown). Several studies
with alphavirus have shown that mutations in the C-terminal protease
domain of nsp2 alter the processing of the replicase (Balistreri et al.,
2007) and noncytopathic mutations in this domain led to either a
hyperprocessing of the replicase (Frolov et al., 1999) or to a slower
processing of this polyprotein (Perri et al., 2000). In our case Western
blot analysis of transfected cells suggested that a hyperprocessing of
the replicase could be taking place in vivo formutant S2-9. This quicker
processing would result in low levels of intermediate nsp123 which is
responsible for minus strand RNA synthesis during the ﬁrst hours after
transfection. Overall, low minus RNA synthesis would lead to lower
genomic and subgenomic RNA levels, as it was observed by Northern
blot. The fact that we were not able to detect differences in replicase
processing between the S2-9 mutant and the wt vector by in vitro
translation (evenwhen the reaction time was reduced to 15 min, data
not shown) could indicate that this process could be affected by
cellular factors not present in vitro. In the case of mutant RHR a slight
effect on the processing of the replicase was also observed in vivo at
24 h posttransfection, although this did not lead to differences in nsp2
expression or cytopathogenicity.
The packaging efﬁciency of the S2-9 mutant was about 6 log lower
than that of awt SFV vector carrying the same transgene. This could be
due either to low RNA replication levels (including helper RNAs), or to
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ments in which the S2-9 mutant was replicated at almost normal
levels by cotransfection of cells with a wt SFV vector were able to
increase the titer of S2-9 viral particles only about 15-fold, indicating
that the low RNA levels were only partially responsible for the low
packaging efﬁciency of this vector. The fact that wt SFV was
simultaneously packaged at normal titers in these cells indicates
that the low packaging efﬁciency of S2-9 was not due to low
replication of helper RNAs. The SFV vector containing only the
R649H mutation was packaged at wt levels, while the SFV vector
containing only mutation P718T (SFV-S2) was packaged very poorly.
Although the fact that vector SFV-S2 was not able to replicate in most
transfected cells could be responsible for this low packaging efﬁciency,
it seemed that this mutation alone or in combinationwith R649H was
affecting the encapsidation of SFV RNA into viral particles. The SFV
packaging signals have been mapped in a region of the genome
comprising nucleotides 2767–2824 (White et al., 1998), which does
not overlap with any of the mutations present in S2-9, located at
positions 3643 (R649H) and 3849–51 (P718T). However, it cannot be
discarded that these mutations could affect the secondary structure of
genomic RNA, altering the accessibility of the packaging signals. More
mutagenesis studies will be required to determine the precise role of
these new sequences in the packaging of SFV.
In spite of the low replication levels of the S2-9mutant the amountof
β-galactosidase producedby SFV-S2-9-LacZat 24hposttransfectionwas
very similar to that obtained from a wt SFV vector expressing the same
transgene. The expression level of S2-9 increased about two-fold at later
times posttransfection, correlating with the observed increase in RNA
levels. The level of recombinant protein expression in other described
noncytopathic vectors has shown a great variability, ranging from only
4% of the wt expression in the case of SIN P726L mutant (Agapov et al.,
1998) to 1000% in the case of the SFV-PD double mutant developed by
Lundstromet al. (2001). However, in the latter case the expression levels
provided by this vector dropped drastically after 3 days postinfection,
probably due to a certain degree of cytopathogenicity in that vector
(Lundstrom et al., 2003). Some additional mutants described by this
group containing temperature sensitive mutations were also able to
express high levels of recombinant proteins, but only at the permissive
temperature (Lundstrom et al., 2003, 2001). The reason why the S2-9
mutant could express higher levels of recombinant protein than the wt
vector having much lower RNA levels could be related to the strong
inhibition of protein synthesis induced by this latter vector. Two
relatively recent publications point out to the phosphorylation of
eIF2alpha as the mechanism by which alphavirus induce host cell
protein shut-off at late times during infection (McInerney et al., 2005;
Ventoso et al., 2006). At the same time these authors showed that the
translation enhancer element present in the 5′ end of the capsid gene
allows efﬁcient translation of the viral structural polyprotein in the
presence of phosphorylated eIF2alpha. When fused in frame with the
amino-terminal end of a recombinant protein in the SFV or SIN vector
the capsid enhancer has shown to increase the level of expression of the
recombinant protein about 8-fold (Frolov and Schlesinger, 1994b;
Sjoberg et al., 1994; Smerdou and Liljestrom, 1999). This effect was not
observed in the context of the S2-9 vector (data not shown), most likely
because no inhibition of translation by eIF2alpha phosphorylation was
taking place in cells transfected with the noncytopathic vector. The
absence of protein synthesis inhibition in cells transfectedwith the S2-9
vector could result inhigh expression levelswithRNA levelsmuch lower
than those reached with the wt SFV vector. A similar observation has
been reported by Gorchakov et al. (2004) with a partially noncytopathic
SIN P726G mutant vector expressing GFP.
Finally we have shown that SFV-S2-9 vector can be efﬁciently used
to generate BHK stable cell lines expressing recombinant proteins. For
that purpose the vector contained the desired transgene and the pac
gene under independent subgenomic promoters and cells were grown
in the presence of puromycin. By using LacZ as reporter transgene wegenerated cell lines that showed very high stability, with 85% of cells
expressing β-gal after 10 passages in culture, and with maintained
expression levels that were similar to those of the wt SFV vector. This is
contrast to what it was observed for a similar β-gal-expressing cell line
generated with a noncytopathic SIN vector carrying mutation P726L in
nsp2, which expressed β-gal at levels about 25-fold lower than wt SIN
(Agapovet al.,1998). In this latter case expressionof LacZwas lost in 50%
of cells after 3–4 passages, although a higher stability could be reached
if the cell line was derived from a cloned population of β-gal positive
cells. Clone selection seemed not to be necessary to obtain highly stable
cell lines with the SFV-S2-9-LacZ-pac vector, which allowed quick
selection of a high number of β-gal-expressing cells upon transfection.
As it has been shown for other alphavirus noncytopathic mutants
(Agapov et al., 1998) the SFV-S2-9 double mutant worked only in BHK
cells, and partially in CHO and Vero cells, (data not shown) probably
due to type I-IFN response defects in these cell lines, that allow them
to sustain RNA replication (Frolova et al., 2002).
In summary, we have developed and characterized a new SFV
noncytopathic vector which is able to express high levels of foreign
proteins in transfected cells. The SFV-S2-9-pac vector could represent a
novel alternative method for rapid generation of stable mammalian
cell lines able to produce recombinant proteins at high levels. These
cell lines could also be very useful to performprotein functional studies
under conditions inwhich the viability of the cells is not compromised.
Materials and methods
Plasmid constructs
Plasmids pSFV-1 and pSFV3-LacZ have been previously described
and were kindly provided by Dr. P. Liljeström (Karolinska Institute,
Stockholm) (Liljestrom and Garoff, 1991). In order to construct
plasmids pSFV-S2 and pSFV-S3, a fragment of 3.5 kb containing the
area of nsp2 to be mutated was extracted from pSFV-1 with SacI/XhoI
and subcloned into pBluescript SK digested with the same enzymes,
generating plasmid Blu-nsp2. Mutations P718T and P718F in nsp2
were introduced into this plasmid by crossover PCR. Outside primers
SF3669-VS (5′-AATGTCACAGGCGCCGATAGG-3′) and SF4096-RS (5′-
GGTGCACACCCGGCCGTGTGC-3′) were combined in sequence with
pairs of oligonucleotides designed to introduce the respective
mutations. For S2, the pair of internal oligos used was mutS2-VS (5′-
GACTGCTAAAAACGGGCGGCAGCCTCTTGATGAGAGC-3′) and mutS2-
RS (5′-AAGAGGCTGCCGCCCGTTTTTAGCAGTCGTAGCGCATC-3′) which
overlap 25 nucleotides and in which codon CCC coding for Pro 718 in
nsp2 has been mutated to ACG coding for Thr (underlined). For S3 the
internal oligos used were mutS3-VS (5′-GACTGCTAAAATTTGGCGG-
CAGCCTCTTGATGAGAGC-3′) and mutS3-RS (5′-AAGAGGCTGCCGC-
CAAATTTTAGCAGTCGTAGCGCATC-3′) which overlap 25 nucleotides
and in which CCC codon coding for nsp2 Pro 718 has been mutated to
TTT coding for Phe (underlined). Crossover PCR was performed with
Pfu and yielded DNA fragments of 430 bp which were digested with
EagI/NarI and cloned into Blu-nsp2 after partial digestion with EagI
and total digestion with NarI, generating Blu-nsp2-S2 or Blu-nsp2-S3,
respectively. The presence of S2 or S3mutations in these plasmids was
conﬁrmed by sequencing. Finally, a 3.5 kb SacI/XhoI fragment
containing mutated nsp2 was extracted from Blu-nsp2-S2 or Blu-
nsp2-S3 and subcloned into pSFV-1 digested with the same enzymes,
generating plasmids pSFV-S2 and pSFV-S3, respectively. In order to
clone LacZ into these plasmids a DNA fragment of 3.86 kb containing
this gene was extracted with XbaI/XmaI from pSFV3-LacZ and cloned
into pSFV-S2 or pSFV-S3 digested with the same enzymes, generating
plasmids pSFV-S2-LacZ and pSFV-S3-LacZ, respectively.
In order to generate plasmid pSFV-pac a DNA fragment of 0.95 kb
containing puromycin N-acetyl-transferase gene (pac) was extracted
from plasmid pBSpac (de la Luna et al., 1988) (kindly provided by Dr. J.
Ortin, CNB, Madrid, Spain) by digestion with NotI and HpaI. Upon
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pSFV-1 digested with SmaI, generating pSFV-pac. pSFV-S2-pac was
generated by substituting the 3.5 kb SacI/XhoI fragment containing
most of nsp2 in pSFV-pac by the same fragment obtained from Blu-
nsp2-S2, containing mutation S2.
Plasmid pSFV-S2-9-LacZ was generated by substituting the 3.2 kb
RsrII/XhoI fragment in pSFV3-LacZ by the same fragment obtained
from pSFV-S2-9-pac which covers the area of the replicase containing
both P718T and R649H nsp2 mutations. In order to generate pSFV-S2-
9-LacZ-pac a DNA cassette of 1.9 kb containing SFV subgenomic
promoter followed by pac gene was extracted from pSFV-pac with
MscI/SpeI, and cloned into pSFV-S2-9-LacZ digested with SmaI/SpeI.
To generate pSFV-RHR-pac, mutation R649H in nsp2 was ﬁrst
introduced into Blu-nsp2 by PCR. Brieﬂy, a PCR fragment of 1.67 kb
was obtained with oligos SF1947-VS (5′-CGGTCCCTGAGTTTCAAG-3′)
and SF3623-S29-RS (5′-AGCACCTATCGGCGCCTGTGACATTCAGCGGT-
GACAACCAAGTGACCCTGTGTCGAGGCAAAGCCAGGTTG-3′) with Pfu
using pSFV-1 as template. In the latter oligo, codon CGC has been
substituted by CAC leading to mutation R649H in nsp2 (underlined,
notice that the primer contains the reverse sequence). The sequence of
this oligo spans the nearby NarI site present in the nsp2 gene (in
italics). The PCR fragment was digested with BstEII/NarI, resulting in a
1.36 kb DNA fragment that was cloned into Blu-nsp2 digested with the
same enzymes, generating in this way Blu-nsp2-RHR. Finally, a 3.5 kb
SacI/XhoI fragment containing mutated nsp2 was extracted from Blu-
nsp2-RHR and subcloned into pSFV-pac digested with the same
enzymes, generating plasmid pSFV-RHR-pac.
RNA transcription and transfection
Puriﬁed plasmid DNAs were linearized by digestion with SpeI and
transcribed in the presence of cap analog (New England Biolabs, USA)
by using SP6 polymerase (Amersham-Pharmacia, USA-Sweden) as
described (Liljestrom and Garoff, 1994). In vitro synthesized RNAs
were transfected into BHK-21 cells by electroporation as described
previously (Liljestrom and Garoff, 1994). In all cases 50 μg of each RNA
were used to transfect 107 BHK cells.
Packaging of replicons
Packaging of recombinant RNA into SFV viral particles was
performed by coelectroporation of BHK-21 cells with the recombinant
RNA and both helper-S2 and helper-C-S219A SFV RNAs as described
(Smerdou and Liljestrom,1999). SFV particles carrying LacZ as reporter
gene were titrated by X-gal staining of BHK cells infected with serial
dilutions of the virus. For SFV particles carrying pac gene indirect
immunoﬂuorescence of infected BHK-21 cells was performed by using
a rabbit polyclonal antiserum speciﬁc for SFV nsp2 as primary
antibody (E. Casales, unpublished results).
Selection and passaging of puromycin-resistant cell lines
Puromycin stocks (1mg/ml) (Sigma, St. Louis, USA)were prepared in
MEM, ﬁltered and stored at −20 °C. After transfection of BHK cells with
recombinant SFV RNAs carrying the pac gene cells were allowed to
recover for 24 h before addition of puromycin at 5 μg/ml. To select for
puromycin resistant cells medium was replaced every 2–3 days with
fresh puromycin containingmedium. Upon selection, cells were always
passaged in the presence of puromycin at the indicated concentration.
In the case of cells transfected with SFV-S2-pac, individual foci were
cloned, expanded and stored frozen in liquid nitrogen.
Mapping of adaptive mutations
Total cellular RNA from puromycin-resistant cells obtained after
transfection with SFV-S2-pac RNA was isolated by using RNeasy kit(Qiagen, Germany). 5 μg of RNA from each clone were used to
synthesize a cDNA with M-MLV reverse transcriptase (Promega,
Madison, USA) by using a negative sense oligonucleotide comple-
mentary to SFV nucleotides 4977–5010 (5′-TCTCGCACTTTACCTTCTG-
CACCCCATCTACATG-3′) as primer. After reverse transcription cDNAs
were ampliﬁed by 30 cycles of PCR with Taq Plus Long (Stratagene, La
Jolla, USA), the same negative sense primer and a positive-sense
oligonucleotide complementary to SFV nucleotides 1040–1074 (5′-
CACAGACACTGTCAAAGGAGAAAGAGTCTCATTCC-3′). The resulting
3971-bp fragment was digested with BclI (1106) and Bsu36I (4916)
and cloned into the corresponding sites of pSFV-pac. Plasmid DNA
derived from each individual clone was linearized and used as
template to synthesize RNA in vitro, which was subsequently
transfected into BHK cells to determine its ability to confer puromycin
resistance. When the subregion comprised between positions 1106–
4916 was able to allow cell survival and division in the presence of
puromycin, as it was the case with clone S2-9, it was completely
sequenced from two independent plasmid clones.
RNA analysis
Total RNAwas extracted from transfected cells or from selected cell
lines by using RNeasy minikit (Qiagen, Germany) and analyzed by
Northern blot. 3 μg of total RNA were size fractionated on a 1.2%
agarose/formaldehyde gel, transferred to a nitrocellulose membrane
(Hybond-N+, Amersham, USA), and hybridized to a 32P-labeled
oligonucleotide speciﬁc for SFV subgenomic promoter (5′-GAATTC-
TGTGTATTAACGCAC-3′). Relative amounts of SFV genomic and
subgenomic RNAs were determined by using a phosphorimager
(Cyclone, Packard, USA) and Optiquant software (version 4.0, Packard).
Analysis of replicase expression and processing
For cell-free translation experiments SFV RNAs were ﬁrst tran-
scribed in vitro as described earlier, puriﬁed with RNeasy kit (Qiagen,
Germany), mixed with nuclease-treated rabbit reticulocyte lysates
(Promega, USA) in the presence of a mixture of [35S]methionine and
[35S]cysteine (Amersham, USA) and incubated for 90 min at 30 °C
according to themanufacturer's instructions. Each translation reaction
contained 2.3 μg of puriﬁed transcript RNA. Translation reactions were
terminated by the addition of Laemmli sample buffer and analyzed by
SDS-PAGE in 8% polyacylamide gels followed by autoradiography. For
Western blot experimentswhole cell lysates from SFV transfected BHK
cells were obtained by incubation in a buffer containing 1% Igepal
(Sigma, St. Louis, USA), 50 mM Tris–HCl pH 7.6, 150 mM NaCl, 2 mM
EDTA and 1 μg/ml PMSF (Sigma, St. Louis, USA), cleared by
centrifugation for 6 min at 6000 rpm in a refrigeratedmicrocentrifuge
and quantiﬁed by Bradford assay. Lysates were analyzed by SDS-PAGE
in 8% polyacylamide gels, transferred to a nitrocellulose membrane
and incubated with a rabbit polyclonal antisera speciﬁc for SFV nsp2
(E. Casales, unpublished results). An HRP-conjugated sheep-anti-
rabbit antiserum was used as secondary antibody. Proteins were
visualized using the Western Lightning Chemiluminiscence Reagent
Plus (Perkin Elmer Life Sciences, USA), scanned with an ImageQuant
ECL imager (GE Healthcare, Chalfont St. Giles, UK) and quantitated
with ImageQuant TL software (GE Healthcare, Chalfont St. Giles, UK).
For nuclear localization studies cytoplasmic and nuclear fractions of
transfected cells were separated previous to Western blot by
resuspending cells in a buffer containing 0.5% Igepal, 10 mM Tris–HCl
pH 8.5, 150mMNaCl, 1.5 mM Cl2Mg and performing 3 cycles of 3-min-
centrifugation at 2000 rpm to pellet cell nuclei. As control of fraction
purity all samples were also analyzed with mouse antibodies speciﬁc
for GAPDH (cytoplasmic protein) (AbD serotec, Kidlington, UK) and
laminA/C (nuclear protein) (Santa Cruz Biotechnology, Santa Cruz,
USA). Immunoﬂuorescence of transfected cells was performed by
using as primary antibody either an Mab speciﬁc for SFV cytoplasmic
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nuclear nsp2 (kindly provided byDr. L. Kaariainen) (Kujala et al.,1997).
Analysis of β-gal expression
Transfected cells were lysed as described earlier and the total β-
galactosidase activity present in the lysate was measured as described
(Liljestrom and Garoff, 1994), or stained at the indicated times with X-
Gal. The amount of protein produced per cell was obtained by dividing
the average amount of β-galactosidase detected per dish by the
average number of cells transfected in each dish.
Acknowledgments
We would like to thank P. Fortes, G. G. Aseguinolaza and R. Aldabe
for fruitful discussions and for critical reading of the manuscript. This
work was supported by grants CICYT (BIO2000-0259), Department of
Education and Culture of the Government of Navarra (IIQ4273), grant
C03/02 from Instituto Carlos III and through the “UTE project CIMA”.
M.R. is a FIS Fellow.
References
Agapov, E.V., Frolov, I., Lindenbach, B.D., Pragai, B.M., Schlesinger, S., Rice, C.M., 1998.
Noncytopathic Sindbis virus RNA vectors for heterologous gene expression. Proc.
Natl. Acad. Sci. U. S. A. 95, 12989–12994.
Balistreri, G., Caldentey, J., Kaariainen, L., Ahola, T., 2007. Enzymatic defects of the nsP2
proteins of Semliki Forest virus temperature-sensitive mutants. J. Virol. 81,
2849–2860.
Berglund, P., Sjoberg, M., Garoff, H., Atkins, G.J., Sheahan, B.J., Liljestrom, P., 1993. Semliki
Forest virus expression system: production of conditionally infectious recombinant
particles. Biotechnology (N Y) 11, 916–920.
Berglund, P., Smerdou, C., Fleeton, M.N., Tubulekas, I., Liljestrom, P., 1998. Enhancing
immune responses using suicidal DNA vaccines. Nat. Biotechnol. 16, 562–565.
Bredenbeek, P.J., Frolov, I., Rice, C.M., Schlesinger, S., 1993. Sindbis virus expression
vectors: packaging of RNA replicons by using defective helper RNAs. J. Virol. 67,
6439–6446.
de la Luna, S., Soria, I., Pulido, D., Ortin, J., Jimenez, A., 1988. Efﬁcient transformation of
mammalian cells with constructs containing a puromycin-resistance marker. Gene
62, 121–126.
Fazakerley, J.K., Boyd, A., Mikkola, M.L., Kaariainen, L., 2002. A single amino acid change
in the nuclear localization sequence of the nsP2 protein affects the neurovirulence
of Semliki Forest virus. J. Virol. 76, 392–396.
Frolova, E.I., Fayzulin, R.Z., Cook, S.H., Grifﬁn, D.E., Rice, C.M., Frolov, I., 2002. Roles of
nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome
of Sindbis virus infection. J. Virol. 76, 11254–11264.
Frolov, I., Schlesinger, S., 1994a. Comparison of the effects of Sindbis virus and Sindbis
virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells.
J Virol 68, 1721–1727.
Frolov, I., Schlesinger, S., 1994b. Translation of Sindbis virus mRNA: effects of sequences
downstream of the initiating codon. J. Virol. 68, 8111–8117.
Frolov, I., Frolova, E., Schlesinger, S., 1997. Sindbis virus replicons and Sindbis virus:
assembly of chimeras and of particles deﬁcient in virus RNA. J Virol 71, 2819–2829.
Frolov, I., Agapov, E., Hoffman Jr., T.A., Pragai, B.M., Lippa, M., Schlesinger, S., Rice, C.M.,
1999. Selection of RNA replicons capable of persistent noncytopathic replication in
mammalian cells. J. Virol. 73, 3854–3865.
Garmashova, N., Gorchakov, R., Frolova, E., Frolov, I., 2006. Sindbis virus nonstructural
protein nsP2 is cytotoxic and inhibits cellular transcription. J. Virol. 80, 5686–5696.
Glasgow, G.M., McGee, M.M., Sheahan, B.J., Atkins, G.J., 1997. Death mechanisms in
cultured cells infected by Semliki Forest virus. J. Gen. Virol. 78, 1559–1563.Glasgow, G.M., McGee, M.M., Tarbatt, C.J., Mooney, D.A., Sheahan, B.J., Atkins, G.J., 1998.
The Semliki Forest virus vector induces p53-independent apoptosis. J. Gen. Virol.
79, 2405–2410.
Gorchakov, R., Frolova, E., Williams, B.R., Rice, C.M., Frolov, I., 2004. PKR-dependent
and-independent mechanisms are involved in translational shutoff during Sindbis
virus infection. J. Virol. 78, 8455–8467.
Kujala, P., Rikkonen, M., Ahola, T., Kelve, M., Saarma, M., Kaariainen, L., 1997. Monoclonal
antibodies speciﬁc for Semliki Forest virus replicase protein nsP2. J. Gen. Virol. 78,
343–351.
Liljestrom, P., Garoff, H., 1991. A new generation of animal cell expression vectors based
on the Semliki Forest virus replicon. Biotechnology (N Y) 9, 1356–1361.
Liljestrom, P., Garoff, H., 1994. Expession of proteins using Semliki Forest virus vectors.
In: Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Smith, J.A., Seidman, J.G.,
Struhl, K. (Eds.), Current Protocols in Molecular Biology, vol. 2. Greene Publishing
Associates and Wiley Interscience, New York, N.Y., pp. 16.20.11–16.20.16.
Lundstrom, K., 2003. Alphavirus vectors for vaccine production and gene therapy.
Expert Rev. Vaccines 2, 447–459.
Lundstrom, K., Rotmann, D., Hermann, D., Schneider, E.M., Ehrengruber, M.U., 2001.
Novel mutant Semliki Forest virus vectors: gene expression and localization studies
in neuronal cells. Histochem. Cell Biol. 115, 83–91.
Lundstrom, K., Abenavoli, A., Malgaroli, A., Ehrengruber, M.U., 2003. Novel Semliki
Forest virus vectors with reduced cytotoxicity and temperature sensitivity for long-
term enhancement of transgene expression. Mol. Ther. 7, 202–209.
McInerney, G.M., Kedersha, N.L., Kaufman, R.J., Anderson, P., Liljestrom, P., 2005.
Importance of eIF2alpha phosphorylation and stress granule assembly in
alphavirus translation regulation. Mol. Biol. Cell 16, 3753–3763.
Perri, S., Driver, D.A., Gardner, J.P., Sherrill, S., Belli, B.A., Dubensky Jr., T.W., Polo, J.M.,
2000. Replicon vectors derived from Sindbis virus and Semliki forest virus that
establish persistent replication in host cells. J. Virol. 74, 9802–9807.
Petrakova, O., Volkova, E., Gorchakov, R., Paessler, S., Kinney, R.M., Frolov, I., 2005.
Noncytopathic replication of Venezuelan equine encephalitis virus and eastern
equine encephalitis virus replicons in Mammalian cells. J. Virol. 79, 7597–7608.
Polo, J.M., Belli, B.A., Driver, D.A., Frolov, I., Sherrill, S., Hariharan, M.J., Townsend, K.,
Perri, S., Mento, S.J., Jolly, D.J., Chang, S.M., Schlesinger, S., Dubensky Jr., T.W., 1999.
Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-
derived vectors. Proc. Natl. Acad. Sci. U. S. A. 96, 4598–4603.
Pushko, P., Parker, M., Ludwig, G.V., Davis, N.L., Johnston, R.E., Smith, J.F., 1997. Replicon-
helper systems from attenuated Venezuelan equine encephalitis virus: expression
of heterologous genes in vitro and immunization against heterologous pathogens in
vivo. Virology 239, 389–401.
Rayner, J.O., Dryga, S.A., Kamrud, K.I., 2002. Alphavirus vectors and vaccination. Rev.
Med. Virol. 12, 279–296.
Rikkonen, M., 1996. Functional signiﬁcance of the nuclear-targeting and NTP-binding
motifs of Semliki Forest virus nonstructural protein nsP2. Virology 218, 352–361.
Sawicki, D.L., Perri, S., Polo, J.M., Sawicki, S.G., 2006. Role for nsP2 proteins in the
cessation of alphavirus minus-strand synthesis by host cells. J. Virol. 80, 360–371.
Sjoberg, E.M., Suomalainen, M., Garoff, H., 1994. A signiﬁcantly improved Semliki Forest
virus expression system based on translation enhancer segments from the viral
capsid gene. Biotechnology (N Y) 12, 1127–1131.
Smerdou, C., Liljestrom, P., 1999. Two-helper RNA system for production of recombinant
Semliki forest virus particles. J. Virol. 73, 1092–1098.
Strauss, J.H., Strauss, E.G., 1994. The alphaviruses: gene expression, replication, and
evolution. Microbiol. Rev. 58, 491–562.
Vasiljeva, L., Merits, A., Golubtsov, A., Sizemskaja, V., Kaariainen, L., Ahola, T., 2003.
Regulation of the sequential processing of Semliki Forest virus replicase
polyprotein. J. Biol. Chem. 278, 41636–41645.
Ventoso, I., Sanz, M.A., Molina, S., Berlanga, J.J., Carrasco, L., Esteban, M., 2006.
Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a
strategy to overcome the antiviral effect of protein kinase PKR. GenesDev. 20, 87–100.
White, C.L., Thomson, M., Dimmock, N.J., 1998. Deletion analysis of a defective interfering
Semliki Forest virus RNAgenomedeﬁnes a region in thensP2 sequence that is required
for efﬁcient packaging of the genome into virus particles. J. Virol. 72, 4320–4326.
Wurm, F., Bernard, A., 1999. Large-scale transient expression in mammalian cells for
recombinant protein production. Curr. Opin. Biotechnol. 10, 156–159.
Xiong, C., Levis, R., Shen, P., Schlesinger, S., Rice, C.M., Huang, H.V., 1989. Sindbis virus:
an efﬁcient, broad host range vector for gene expression in animal cells. Science
243, 1188–1191.
